IMR Press / JIN / Special Issues / MicroRNAs_neuroscience

MicroRNAs in Central Nervous System Disorders: Molecular, Cellular and Translational Neuroscience

Submission deadline: 31 March 2024
Special Issue Editor
  • Christian Barbato, MD, PhD
    Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Department of Sense Organs, University Sapienza of Rome, Rome, Italy
    Interests: translational biomedicine; cellular and molecular neurobiology; neurodegenerative diseases; RNA-non-coding; microRNA; post-COVID-19 syndrome
    Special Issues and Topics in IMR Press journals
Special Issue Information

Dear Colleagues,

Molecular and cellular microRNA (miRNA) research in the central nervous system represents the exploration of a new frontier of miRNA biology and the potential development of new translational insight for neurological disease. In recent years our understanding of molecular mechanisms by which miRNAs regulate gene expression, and their functional roles, has been expanded. MicroRNAs are a large family of conserved small, 20–22 length nucleotides, non-coding RNAs, widely expressed in all organisms and highly expressed in the human central nervous system. MiRNAs regulate neuronal gene expression and play a pivotal role in physiological and pathological diseases. Basic and clinical research has demonstrated miRNA dysregulation in several acute and chronic neurological disorders. The collection of data on the association between human brain diseases and miRNAs has focused on expression profiles of miRNAs and their quantitative modulation according to age, gender, phase of the disease, and a specific brain area. Given the importance that miRNAs might play in neuropathology, several strategies to manipulate miRNA activity and their expression are being pursued. The main challenge for miRNA therapeutics in neurology, beyond stability and safety, is their delivery to the appropriate tissue and neurons.

The aim of this Special Issue entitled ‘MicroRNAs in Central Nervous System Disorders: molecular, cellular and translational neuroscience’ is to explore the recent progress on miRNAs and future directions, in the neurobiology of neurological and psychiatric diseases. Original and review articles from this Special Issue will provide recent molecular, cellular, and translational neuroscience studies that highlight the role of miRNAs in Central Nervous System Disorders.

Dr. Christian Barbato 
Guest Editor

Keywords
microRNAs
non-coding RNA
neurobiology
neuropathology
neurological diseases
neurodegenerative diseases
motor neuron diseases
neuropsychiatric diseases
neurotherapeutics
translational neuroscience
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Planned Paper (1 Paper)
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to IMR Press journals will subject to peer-review before acceptance

MicroRNAs in COVID-19-Associated Cognitive Impairment

Christian Barbato et al.

Published Paper (1 Paper)
Back to top